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ABSTRACT
Objective: The present study is aimed to estimate the serum toll-like receptor 4 (sTLR 4) and nuclear factor-κB (NF-κB) p65 proteins in patients of 
oral squamous cell carcinoma (OSCC).
Methods: The study was performed in prospective cases of 22 OSCC patients, 10 oral epithelial dysplasia patients, 8 control with chewing habits, 
and 4 control patients. The estimation of sTLR 4 and NF-κBp65 proteins was done by enzyme-linked immunosorbent assay method. The Pearson 
correlation test was performed to find out the relationship between these two proteins.
Results: There was an increase in the sTLR 4 protein level in study groups OSCC, oral premalignant disorders, control with chewing habits, and 
control habits such as 1.31 ng/ml±1.06 ng/ml, 1.99 ng/ml±0.98 ng/ml, and 2.11 ng/ml±0.61 ng/ml, respectively, when comparable (p=0.008) to 
control patients with 0.60 ng/ml±0.24 ng/ml. However, in the case of serum level NF-κBp65 protein all the study groups including the control showed 
same values. The Pearson correlation test showed significant relationship (rpearson=0.91, [p<0.0005]) of these two proteins only in the OSCC patients.
Conclusion: It can be concluded that serum levels of TLR 4 are increased in OSCC patients, but there was no variation seen for the NF-κBp65 protein. 
There is a strong interrelationship exist between the serum levels of TLR 4 and NF-κBp65 proteins in the OSCC patients only.
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INTRODUCTION
Oral cancer, malignant neoplasm ranks 3rd among the cancer types 
with a prevalence of 45% in India and about 90–95% of squamous 
cell carcinoma is the 12th most prevalent neoplasm globally [1-4]. Oral 
squamous cell carcinoma (OSCC) constitutes more than 90% of head 
and neck malignancies and ranks 6th among all other cancers which 
are the cause for high morbidity and mortality worldwide with an high 
incidence rate that varies widely by geographic location [5,6]. However, 
nearly 3–6% of the OSCC patients were predominantly observed in the 
western countries, while the rate was higher with 30% among the east 
including Indonesia [7]. Rapid cell division leads to clinical hypoxia 
causing the releases of pro-inflammatory mediators that, in turn, enlist 
inflammatory cells. In particular, nuclear factor-κB (NF-κB) which acts 
as an important intermediate between inflammation and cancer [8,9] 
also exerts dual action of both protumorigenic and cell survival 
mechanism [10,11]. Hence, it is considered as valuable therapeutic 
target [12]. Its activation is mediated by three molecules such as toll-like 
receptors (TLRs), interleukin-1 receptor, and the tumor NF receptor. TLRs, 
type I transmembrane protein identifies conserved microbial structures/
patterns and was previously thought to play a critical role in host defense 
against wide range of organisms from bacteria to protozoa [13]. Recently, it 
is known that many cancer cells express TLRs and till now, 13 mammalian 
TLRs have been demonstrated, but in humans, only 11 are expressed. 
Recent data had demonstrated that OSCC could modulate TLRs protein 
expression and function in variety of immune cells [14]. Hence, TLR role 
in rapid cell proliferation and metastasis of oral cancer was established. 
The association of TLRs with NF-kBp65 with different malignancies in 
patients with OSCC was also described [15,16]. However, the mechanism 
behind the interactions was not completely understood.
Many molecular markers had been proposed for the better survival 
of OSCC patients, but none are available in clinical benefit. Hence, 
early identification of ideal therapeutic targets is mandatory. Studies 
pertaining to the relationship of serum TLR 4 (sTLR 4) and serum NF-κB 
(sNF-kB) p65 for OSCC are considered to be inadequate. Hence, the 
objective of the study is to analyze the sTLR 4 and sNF-kBp65 level in our 
samples using enzyme-linked immunosorbent assay (ELISA) to identify 
diagnostic and as well as prognostic values in our study populations.
METHODS
Subject characteristics
The study was approved by the Institution Ethics Committee of (a) A.C.S 
Medical College, Chennai, (b) Sree Balaji Dental College and Hospital, 
Chennai, and (c) Government Tertiary Care Centre, Chennai. The 
written informed consent was obtained from all the patients (n=44) 
for the prospective samples by surgical oncologist and dental surgeons, 
respectively. Patient details were collected based on the structured 
questionnaire and blood samples were obtained from patients which 
includes OSCC and oral premalignant disorders (OPMDs) control with 
chewing habits and absolute control samples.
Sample collection and ELISA for TLR 4 and NF-κB p65 proteins
Peripheral blood samples were obtained from patients under aseptic 
condition and collected in non-heparinized tubes. The serum was 
separated by centrifuging the samples at 1000 rpm for 15 min. The 
samples were stored at −80 until further use. ELISA was performed with 
the help of commercially available human TLR 4 (Catalog No: E-EL-H1539, 
ELabscience, USA) and NF-κB p65 (Catalog No: E-EL-H1388), by 
following manufacturing instruction. Optical density was determined of 
each microtiter well and plate was read at 450 nm using ELISA reader.
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
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Statistical analysis
All statistical analyses were performed with the help of Statistical 
Package for the Social Sciences version 20.0 (Chicago, IL, USA). 
Numerical data were expressed as the mean ± standard deviation. 
The comparisons of numerical data were performed by independent 
sample t-test, categorical variables were performed with Chi-square 
test or Fisher’s exact test and Mann–Whitney test for continuous 
variables was used. The correlation between sTLR 4 and sNF-κBp65 
level was calculated using Pearson correlation. p<0.05 was considered 
to be statistically significant.
RESULTS
Baseline characteristics of different study group patients
The baseline clinical characteristics of the study populations are 
given below. Both male and female were grouped as OSCC (n=22), 
oral epithelial dysplasia (OED) (n=10), control with chewing habits 
(n=8), and absolute control patients (n=4). Overall, the mean age 
of the study group for each population was between 48.3 years 
for OSCC(ranged 33-69 years), 47.2 years for OED(ranged  32-64 
years), 50 years for Control with chewing habits(ranged 33-65 
years), and 49.7 years(ranged 33-80 years) for absolute control 
patients. When considering the gender, 81.8% of patients belong 
to male populations and only 18.2% of patients were categorized 
as female patients. When the tobacco consumption is considered 
77.3% in OSCC, 90% in OED, and 100% in control with chewing 
habits, patients were found to be the active tobacco users against 
the control patients with nil tobacco consumptions. Tobacco users in 
the form of smoking habits are considered, OSCC 40.9%, OED 60%, 
and nil in control with chewing habits, and control patients were 
included for the study. Among the OSCC patients and OED patients, 
18.2% and 60% were had the habits of alcohol consumption against 
the control with chewing habits and absolute control with no alcohol 
usage.
Correlation of serum level expression of sTLR 4 with baseline 
characteristics of different study group patients
In the present investigation, sTLR 4 levels were found to be increased 
in OSCC, OPMD, and control with chewing habit patients when 
comparable to absolute control patients (Table 1) which may be 
correlated with their tobacco usage. In the present investigation, age 
group of >45 showed an increased level of sTLR 4 in all the study groups 
when compared to the age groups of ≤45. While considering the gender, 
both male and female populations exhibited almost the same levels in 
all the study populations. In the present investigation, it was noticed 
that non-smokers had a high level of sTLR 4 when compared to smokers 
in all the study population. Similarly, all habitual users exhibited high 
level of TLR 4 in OSCC patients and non-habitual users exhibited high 
level of TLR 4 in OED patients. The control with chewing habits and 
absolute control patients we could not do proper comparison as far 
as smoking habit, alcohol, and non-chewing habits is concerned since 
the cases were significantly less. The alcohol users exhibited high level 
of TLR 4 when comparable to non-alcoholic users (OSCC p=0.280 and 
OED p=0.057). Since it is a customary to do the TNM staging only for 
OSCC, we analyzed the correlations of the levels of the TLR 4 to the TNM 
staging in OSCC patients alone. It is observed that patients belonging 
to T4 stage have an increased level of sTLR 4 when comparable to the 
patients in the stage of T2.
Correlation of serum level expression of sNF-κBp65 in with 
baseline characteristics of different study group patients
In the present investigation, there is no significant variation in the sNF-
κBp65 levels was found among the study population such as OSCC, 
OPMD, and control with chewing habits and absolute control patients 
(Table 2). Similar to TLR 4 age group of >45 showed an increased level 
of Nfkpb65 in all study groups. While considering the gender, female 
population showed high level of sNF-κBp65 when compared to male 
populations (p=0.013) in OSCC patients and low level of sNF-κBp65 in 
female populations when compared to male in OED cases (p=0.502). 
Table 1: Quantification of sTLR 4 in OSCC and OED patients
Variable n (%) OSCC patients sTLR 4 (ng/ml) 
mean±SD




>45 12 1.45±1.14 ng/ml 0.497 5 2.2±0.7 ng/ml 0.545
≤45 10 1.139±0.995 ng/ml 5 1.795±1.20 ng/ml
Gender
Male 18 1.167±0.916 ng/ml 0.175 8 1.9±1.0 ng/ml 0.648
Female 4 1.97±1.57 ng/ml 2 2.3±0.5 ng/ml
Tumor stage
T2 6 1.248±1.35 ng/ml 0.864 0 NA NA
T4 16 1.33±0.988 ng/ml 0 NA NA
Smoking
Yes 9 1.112±1.187 ng/ml 0.473 6 1.97±0.69 ng/ml 0.928
No 13 1.454±0.998 ng/ml 4 2.03±1.44 ng/ml
Chewing
Yes 17 1.443±1.116 ng/ml 0.305 9 2.04±1.02 ng/ml 0.651
No 5 0.8744±0.815 ng/ml 1 1.54±0.0 ng/ml
Alcohol
Yes 4 0.782±0.783 ng/ml 0.280 6 2.46±0.92 ng/ml 0.057
No 18 1.432±1.101 ng/ml 4 1.29±0.60 ng/ml
Chewing with smokers
Yes 7 1.36±1.027ng/ml 0.742 5 2.060±0.7437 ng/ml 0.856
No 15 1.200±1.22ng/ml 5 1.93±1.267 ng/ml
Smoking with alcohol
Yes 3 0.649±0.903 ng/ml 0.255 4 2.109±0.854 ng/ml 0.790
No 19 1.41±1.07 ng/ml 6 1.92±1.13 ng/ml
Chewing with alcohol 
Yes 2 1.08±0.700 ng/ml 0.759 5 2.65±0.901 ng/ml 0.023
No 20 1.33±1.106 ng/ml 5 1.34±0.532 ng/ml
All habits
Yes 2 1.33±1.10 ng/ml 0.759 7 1.86±1.04 ng/ml 0.554
No 20 1.08±0.700 ng/ml 3 2.298±0.937 ng/ml
sTLR 4: Serum toll-like receptor 4, OSCC: Oral squamous cell carcinoma, OED: Oral epithelial dysplasia, SD: Standard deviation
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However, tobacco users had a high level of sNfkpb65 (OSCC p=0.020 
and OED p=0.554) when compared to non-tobacco users in the case 
of all study populations. Interestingly, increased sNfkpb65 levels 
were observed in non-smokers and even in non- alcohol users when 
compared to smokers and alcohol users in OSCC and OED patients. The 
control with chewing habits and absolute control patients we could 
not do proper comparison as far as smoking habit, alcohol, and non-
chewing habits is concerned since the cases were significantly less. 
Since it is a customary to do the TNM staging only for OSCC, we analyzed 
the correlations of the levels of the TLR 4 to the TNM staging in OSCC 
patients alone. It is observed that patients belonging to T4 stage have 
an increased level of sNF-κBp65 when comparable to the patients in the 
stage of T2 (p=0.809).
Correlation ship between sTLR 4 and sNF-κBp65 concentrations
The Pearson correlation test showed that the TLR 4 expression in the 
serum of OSCC was positively correlated with NF-κBP65 expression 
(rpearson=0.91, [p<0.0005]) was found to be statistically significant among 
OSCC groups (Fig. 1). In OPMD patients, TLR 4 expression in the serum 
was negatively correlated with NF-κBp65 expression (rpearson=−0.08, 
[p=0.81]). Similarly, among the control with chewing habits patients, the 
sTLR 4 expression was positively correlated with NF-κBp65 expression 
(rpearson=0.30, [p=0.70]). Among the absolute control patients, the TLR 
4 expression level in serum was found to be negatively correlated with 
NF-κBp65 expression (rpearson=−0.88, [p=0.11]).
DISCUSSION
In our present study, we have quantified the serum level of sTLR 4 and 
sNF-κBp65 in various study group populations. TLR 4 is considered as 
most important protein molecule which is involved in both non-specific 
and specific immune response [17,18]. TLR 4 is the important regulator 
of immune mechanism and is a single transmembrame non-catalytic 
protein which provides a microenvironment for the tumor cells to 
proliferate and as well to evade the immune response [19]. Recent 
studies have reported that TLRs are overexpressed in the various 
types of tumors. In our present investigation, significantly high TLR 4 
level was observed in OSCC and control with chewing habits group of 
patients. Our results are comparable with studies performed by Wei 
et al., 2016 [20], on non-small cell lung cancer (NSCLC) patients where 
he showed a higher TLR 4 serum levels when compared to the healthy 
controls. Similarly, another study revealed from radiation pneumonia in 
locally advanced NSCLC exhibited higher level of TLR 4 levels in NSCLC 
patients when compared to healthy controls [21].
NF-κB, an important key regulator for transcription factor, is the 
major contributor of carcinogenesis which triggers the important 
Table 2: Quantification of sNFKBp65 in OSCC and OED patients
Variable n (%) OSCC patients sNF-kBp65 (ng/ml) 
mean±SD




>45 12 0.585±0.749 ng/ml 0.312 5 0.304±0.395 ng/ml 0.565
≤ 45 10 0.314±0.460 ng/ml 5 0.18±0.17 ng/ml
Gender
Male 18 0.309±0.457 ng/ml 0.013 8 0.279±0.32 ng/ml 0.502
Female 4 1.15±0.933 ng/ml 2 0.11±0.05 ng/ml
Tumor stage
T2 6 0.406±0.87 ng/ml 0.809 0 NA NA
T4 16 0.483±0.557 ng/ml 0 NA NA
Smoking
Yes 9 0.290±0.503 ng/ml 0.303 6 0.33±0.3 ng/ml 0.248
No 13 0.581±0.708 ng/ml 4 0.10±0.13 ng/ml
Chewing
Yes 17 0.567±0.687 ng/ml 0.020 9 0.2±0.3 ng/ml 0.554
No 5 0.105±0.161 ng/ml 1 0.4±0.0 ng/ml
Alcohol
Yes 4 0.196±0.279 ng/ml 0.368 6 0.33±0.3 ng/ml 0.248
No 18 0.521±0.682 ng/ml 4 0.1±0.14 ng/ml
Chewing with smokers
Yes 7 0.364±0.551 ng/ml 0.632 5 0.320±0.384ng//ml 0.456
No 15 0.508±0.684 ng/ml 5 0.171±0.1815 ng/ml
Smoking with alcohol
Yes 3 0.162±0.332 ng/ml 0.392 4 0.424±0.400 ng/ml 0.122
No 19 0.509±0.664 ng/ml 6 0.127±0.131 ng/ml
Chewing with alcohol
Yes 2 0.288±0.354 ng/ml 0.696 5 0.320±0.380 ng/ml 0.456
No 20 0.479±0.660 ng/ml 5 0.171±0.190 ng/ml
All habits
Yes 2 0.288±0.354 ng/ml 0.696 3 0.424±0.490 ng/ml 0.465
No 20 0.479±0.660 ng/ml 7 0.169±0.164 ng/ml
sNF-κB: Serum nuclear factor-κB, OSCC: Oral squamous cell carcinoma, OED: Oral epithelial dysplasia, SD: Standard deviation
Fig. 1: Pearson correlation analysis of toll-like receptor 4 and 
nuclear factor-κBp65 in oral squamous cell carcinoma
182
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 179-182
 Sathiyamoorthy et al. 
signaling pathway involved in the tumor progression such as 
TLR [22]. In almost all tumors such as breast, lung, and skin cancers, 
it is been expressed [23-25]. NF-κB family comprised homologous or 
heterologous dimers, among which the heterologous dimer of p50 and 
p65 is considered as most important dimer and NF-κB p65 plays an 
important nuclear transcription factor [26-28]. A study performed by 
Wei et al. [29] on gastric cardia adenocarcinoma showed the increased 
serum level of NF-κBp65. Similar, to the above studies performed in 
other cancers, our study also revealed that significant association 
was seen between sNF-κBp65 level and tobacco users. Hence, from 
our present study, we evaluated both levels of sTLR 4 and sNF-κBp65 
expression in a relatively smaller sample size. However, there might be 
also some possible reason for TLR 4/NF-κB p65 activation in various 
factors which is not manifested in peripheral blood samples as it is 
rarely investigated. Hence, further studies are needed to validate 
with the large number of samples to evaluate sTLR 4 and sNF-κBp65 
whether can be used as prognostic marker or not for OSCC patients.
CONCLUSION
To our understanding, this is our first study to report on TLR 4 and NF-
κBp65 in serum samples. Although TLR 4 and NF-κBp65 are considered 
as well-known diagnostic markers, the studies pertaining to OSCC seem 
to be very limited. Hence, probable targeted therapy with these above 
markers can help in near future for OSCC patients.
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